# Nordmark Arzneimittel GMBH & Co. KG - Inspection Records

Source: https://www.keypedia.com/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b

> Inspection records and compliance data for Nordmark Arzneimittel GMBH & Co. KG in Uetersen, None. Access full analysis and detailed observations.

---

## Details

- Name: Nordmark Arzneimittel GMBH & Co. KG
- FEI Number: 3003293533
- City: Uetersen
- State: None
- Country Name: Germany
- Address Line 1: Pinnauallee 4
- Zip Code: None

## Related Documents

- [483 - Nordmark Arzneimittel GMBH & Co. KG - 2025-02-13](https://www.keypedia.com/records/483/nordmark-arzneimittel-gmbh-co-kg/ce2cce0a-4145-435d-8ea6-0a133b4391bc) — source: FDA, date: February 13, 2025
- [483 - Nordmark Arzneimittel GMBH & Co. KG - 2025-02-13](https://www.keypedia.com/records/483/nordmark-arzneimittel-gmbh-co-kg/224c37dc-569f-4745-ba9a-33fc53d845e5) — source: FDA, date: February 13, 2025
- [FDA Inspection 1263912 - Nordmark Arzneimittel GMBH & Co. KG - 2025-02-13](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/2deb9c88-7f3a-400e-8a1f-9888c509eb7b) — source: FDA, date: February 13, 2025
- [FDA Inspection 1263912 - Nordmark Arzneimittel GMBH & Co. KG - 2025-02-13](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/4a4a9a5f-3566-48a4-a5df-27abf97f407c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2025
- [FDA Inspection 1241654 - Nordmark Arzneimittel GMBH & Co. KG - 2023-08-31](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/27b670f2-28bd-4215-999e-3ba4fe92200f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 31, 2023
- [FDA Inspection 1099709 - Nordmark Arzneimittel GMBH & Co. KG - 2019-08-16](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/65cc61b2-c4a2-4b16-8979-09c66710a18d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 16, 2019
- [483 - Nordmark Arzneimittel GMBH & Co. KG - 2019-08-12](https://www.keypedia.com/records/483/nordmark-arzneimittel-gmbh-co-kg/fa4f589e-ae28-472d-955e-bf5887a2b503) — source: FDA, date: August 12, 2019
- [FDA Inspection 1006686 - Nordmark Arzneimittel GMBH & Co. KG - 2017-02-17](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/19e24e38-6d17-4f42-b4ba-8519cb457d81) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 17, 2017
- [483 - Nordmark Arzneimittel GMBH & Co. KG - 2017-02-13](https://www.keypedia.com/records/483/nordmark-arzneimittel-gmbh-co-kg/eef74cad-0c2c-43b0-bf4b-3616c0a31761) — source: FDA, date: February 13, 2017
- [FDA Inspection 907095 - Nordmark Arzneimittel GMBH & Co. KG - 2014-11-20](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/ec95f3fd-18ff-41fd-b6ce-e07928c08fdd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2014
- [FDA Inspection 810090 - Nordmark Arzneimittel GMBH & Co. KG - 2012-11-29](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/984012a2-ba66-4e48-8f86-eff9cf9c2f6a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 29, 2012
- [FDA Inspection 653161 - Nordmark Arzneimittel GMBH & Co. KG - 2010-02-26](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/005c966f-59e9-4280-aa36-24b763f201e5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2010
- [FDA Inspection 580439 - Nordmark Arzneimittel GMBH & Co. KG - 2009-04-09](https://www.keypedia.com/records/fda_inspections/nordmark-arzneimittel-gmbh-co-kg/17e1023e-682f-4162-9548-70ad5401163e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 9, 2009

## Related Companies

- [Baxalta Belgium Manufacturing SA](https://www.keypedia.com/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9)
- [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)
- [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f)
- [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70)
- [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Novartis Pharma Stein AG](https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b)
- [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38)
- [Ferring Microbiome Inc.](https://www.keypedia.com/companies/ferring-microbiome-inc/860d4130-d93a-4017-97ca-30033280de85)
- [Amgen Manufacturing Ltd](https://www.keypedia.com/companies/amgen-manufacturing-ltd/cecb788c-4cd6-4c26-9331-7b68b4f12369)
- [Biological E. Limited](https://www.keypedia.com/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4)

## Related Officers

- [National Program Expert- Pharmacy Compounding](https://www.keypedia.com/people/lucila-b-nwatu/3d1c9670-8206-425c-bddd-32e395293042)
- [Investigator](https://www.keypedia.com/people/charles-l-zhou/b55d1247-06de-4c7e-80d8-5ed2f801d259)
- [company_representative](https://www.keypedia.com/people/michael-correa/52d11b7e-2372-4052-9998-2ce9a0382d65)